Kanser

Cancer (massgeneralbrigham.org):
New Blood Test Developed at Mass General Brigham Shows Superior Sensitivity in Detecting HPV-Associated Head and Neck Cancers
Cancer (utu.fi):
New antibody-drug bexmarilimab can activate the body's defense system against cancer. This activation occurs especially when the tumor microenvironment is immunologically silent. Researchers also discovered that patients who benefit from the drug can be identified by measuring their gene signature.
Cancer (doi.org):
Advancements in bladder cancer treatment: The synergy of radiation and immunotherapy
Cancer (pubmed.ncbi.nlm.nih.gov):
Microplastics and the Rising Tide of Early-Onset Colorectal Cancer: Exploring the Environmental Gut Connection
Cancer (news.cancerresearchuk.org):
Partnering olaparib with chemotherapy helps treat BRCA breast cancers
Cancer (nature.com):
A study found that "cannabidiol potentiates p53-driven autophagic cell death in non-small cell lung cancer following DNA damage."
Cancer (ashpublications.org):
Leukaemia patients have 61% lower death risk with statins. New research suggests that statins—one of the most commonly prescribed cholesterol medications—may help prevent deaths when taken during blood cancer treatment.
Cancer (massgeneralbrigham.org):
Mass General Brigham Study Finds That Patients with Glioblastoma Who Received Gabapentin Lived Longer
Cancer (journals.plos.org):
The impact of mutations on TP53 protein and MicroRNA expression in HNSCC: Novel insights for diagnostic and therapeutic strategies
Cancer (nature.com):
DNA remnants in red blood cells enable early detection of cancer. Remnants of DNA found in red blood cells (rbcDNA) hold significant promise for early cancer diagnosis by identifying unique genomic signatures in rbcDNA from patients with early-stage solid tumors.